Randomized controlled trial of asthma risk with paracetamol use in infancy--a feasibility study

J Riley1, I Braithwaite, P Shirtcliffe

  • 1Medical Research Institute of New Zealand, Wellington, New Zealand.

Insights

This study explored feasibility for a paracetamol (acetaminophen) and childhood asthma trial. Ibuprofen emerged as the preferred comparator for future randomized controlled trials investigating paracetamol

Area of Science:

  • Pediatric pharmacology
  • Clinical trial methodology
  • Respiratory medicine

Background:

  • Observational studies suggest a link between paracetamol (acetaminophen) use and increased asthma risk in children.
  • Methodological challenges in previous research necessitate a randomized controlled trial (RCT) to confirm this association.
  • Investigating paracetamol's role in childhood asthma requires careful consideration of trial design and comparators.

Purpose of the Study:

  • To assess the feasibility of conducting an RCT examining liberal versus restricted paracetamol (acetaminophen) dosing in infants.
  • To determine parental preferences for comparator treatments, including restricted paracetamol, ibuprofen, or placebo.
  • To establish a suitable comparator for future RCTs on paracetamol use and childhood asthma risk.

Main Methods:

  • A feasibility study involving questionnaires on parental preferences for comparator treatments (ibuprofen, restricted paracetamol, placebo).
  • Infants with bronchiolitis were randomized to either a restricted or liberal paracetamol dosing regimen for three months.
  • Paracetamol consumption was recorded through parental reporting and direct measurement.

Main Results:

  • Parental acceptance rates varied: ibuprofen (58%), restricted paracetamol (40%), and placebo (12%).
  • A significant difference in paracetamol dosing was achieved between the liberal (median reported use 2.0-fold higher) and restricted groups (median measured use 3.5-fold higher).
  • The study successfully randomized 30% of eligible infants to the paracetamol dosing arms.

Conclusions:

  • A liberal versus restricted paracetamol regimen can effectively create dosing separation for an RCT.
  • Ibuprofen is identified as the most suitable comparator for future RCTs investigating the relationship between paracetamol use and childhood asthma.
  • This feasibility study provides crucial insights for designing a definitive RCT on paracetamol and asthma risk.
Abstract

Related Concept Videos

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
1.7K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
26
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.5K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.5K
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
22